Cytokinetics Incorporated

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Cytokinetics Incorporated
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Headquarters city: South SAN Francisco
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: CYTK
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001061983
EIN: 94-3291317
Wikidata ID: Q30283314

Board of directors

Follow this board

B. Lynne Parshall · Director
Since 2023
Edward M. Kaye M.D. · Director
Since 2023
James M. Daly · Director
Since 2025
John T. Henderson · Director
Since 2023
Muna Bhanji · Director
Since 2023
Nancy Wysenski · Director
Since 2023
Robert Arthur Harrington · Director
Since 2023
Robert E. Landry · Director
Since 2025
Robert I. Blum · Director · President & CEO
Since 2023
Sandford D. Smith · Director
Since 2023
Santo J. Costa · Director
Since 2023
Wendall Wierenga · Director
Since 2023
Wendell Wierenga · Director
Since 2025

Chief executives

Robert I. Blum · President & CEO

Dates unknown

Director election results

Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

8 of this board's directors also sit on 13 other boards. 13 are in the same sector.

Shared director Other board Same sector

ACADIA Pharmaceuticals Inc. Same sector
via James M. Daly
Alkermes plc Same sector
via Nancy Wysenski
Aquestive Therapeutics Inc. Same sector
via Santo J. Costa
Ardelyx Inc. Same sector
via Muna Bhanji
Dermata Therapeutics Inc. Same sector
via Wendell Wierenga
Foghorn Therapeutics Inc. Same sector
via B. Lynne Parshall
Halozyme Therapeutics Inc. Same sector
via James M. Daly
Intellia Therapeutics Inc. Same sector
via Muna Bhanji
Ionis Pharmaceuticals Inc. Same sector
via B. Lynne Parshall
Madrigal Pharmaceuticals Inc. Same sector
via James M. Daly
Stoke Therapeutics Inc. Same sector
via Edward M. Kaye M.D.
Veracyte Inc. Same sector
via Muna Bhanji
Zymeworks Inc. Same sector
via Robert E. Landry

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $51,718,084; 84 sales by 10 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 3, 2026	Fady Ibraham Malik Officer (EVP Research & Development)	Option exercise	+3,500	$7.80	$27,300
Nov 3, 2026	Fady Ibraham Malik Officer (EVP Research & Development)	Open-market sale	−3,500	$62.93	$220,255
Nov 2, 2026	Robert I. Blum Director, Officer (President & CEO)	Option exercise	+7,500	$10.60	$79,500
Nov 2, 2026	Robert I. Blum Director, Officer (President & CEO)	Open-market sale	−7,500	$62.81	$471,075
Oct 20, 2026	Fady Ibraham Malik Officer (EVP Research & Development)	Option exercise	+3,500	$7.80	$27,300
Oct 20, 2026	Fady Ibraham Malik Officer (EVP Research & Development)	Open-market sale	−3,500	$64.01	$224,035
Oct 16, 2026	John T. Henderson Director	Grant or award	+352	$63.92	$22,500
Oct 16, 2026	Wendell Wierenga Director	Grant or award	+97	$63.92	$6,200
Oct 16, 2026	James M. Daly Director	Grant or award	+195	$63.92	$12,464
Oct 16, 2026	Robert Arthur Harrington Director	Grant or award	+195	$63.92	$12,464
Oct 16, 2026	Edward M. Kaye M.D. Director	Grant or award	+195	$63.92	$12,464
Oct 16, 2026	Nancy Wysenski Director	Grant or award	+97	$63.92	$6,200
Oct 12, 2026	Robert I. Blum Director, Officer (President & CEO)	Option exercise	+7,500	$10.60	$79,500
Oct 12, 2026	Robert I. Blum Director, Officer (President & CEO)	Open-market sale	−7,500	$62.88	$471,600
Oct 6, 2026	Fady Ibraham Malik Officer (EVP Research & Development)	Option exercise	+3,500	$7.80	$27,300

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Cytokinetics Incorporated

Who is the CEO of Cytokinetics Incorporated?

Robert I. Blum is Cytokinetics Incorporated's President & CEO.

How many directors are on Cytokinetics Incorporated's board?

Cytokinetics Incorporated's board has 13 directors: B. Lynne Parshall, Edward M. Kaye M.D., James M. Daly, John T. Henderson, Muna Bhanji, Nancy Wysenski, Robert Arthur Harrington, Robert E. Landry, Robert I. Blum, Sandford D. Smith and 3 others.

Are Cytokinetics Incorporated insiders buying or selling shares?

Over the last 12 months, Cytokinetics Incorporated insiders made no open-market purchases and sold $51.7 million of shares in 84 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Cytokinetics Incorporated connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cytokinetics-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.